GENEVA, Aug. 21 -- MINGHUI PHARMACEUTICAL (HANGZHOU) LIMITED filed a patent application (CN2026/077613) for “ANTI-CDCP1 ANTIBODY-DRUG CONJUGATE AND USE THEREOF”. With publication no. WO/2026/171088, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....